About this trial
The purpose of this study is to evaluate the control effect of smart wearable devices on key risk factors in the high-risk populations for stroke
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosed with hypertension;
Diagnosed with diabetes;
Diagnosed with atrial fibrillation;
Smoking subjects;
Disqualifiers
Diagnosed with malignancies;
Diagnosed with psychiatric disorders;
Diagnosed with cognitive impairment;
Unable to operate smart wearable devices.
Trial design
Parallel
Treatments tested in this trial
Wearable Devices
BehavioralParticipants utilize wearable devices (smart wristbands) 24 hours a day for 6 months. Wearable devices can provide medication reminders for each use and heart rate monitoring.
Treatment groups
Trial outcomes
Primary outcomes
medication adherence and risk factor control rates
1.The medication rates and control rates for hypertension; 2.The medication rates and control rates for hyperglycemia; 3. The medication rates and control rates for hyperlipidemia; 4.The medication rates and control rates for obesity.
Secondary outcomes
incident vascular events, including stroke, coronary heart disease (CHD), peripheral vascular disease (PVD), and other related cardiovascular events
Stroke is a sudden interruption of blood flow to the brain, caused by either a blockage (ischemic stroke) or rupture of a blood vessel (hemorrhagic stroke). Coronary heart disease is a cardiovascular condition characterized by the narrowing or blockage of the coronary arteries, the blood vessels that supply oxygen-rich blood to the heart muscle. Peripheral vascular diseases are circulatory disorders characterized by narrowing, blockage, or spasms in blood vessels outside the heart and brain, most commonly affecting arteries supplying the legs, arms, kidneys, or stomach.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.